Crossmark

The immune-opioid axis in prediabetes: predicting prediabetes with insulin resistance by plasma interleukin-10 and endomorphin-2 to kappa-opioid receptors ratio

Crossref DOI link: https://doi.org/10.1186/s13098-021-00677-w

Published Online: 2021-06-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moustafa, Shatha Rouf
License Information

Text and Data Mining valid from 2021-06-07

Version of Record valid from 2021-06-07
More Information

Article History

Received: 18 November 2020

Accepted: 20 May 2021

First Online: 7 June 2021

Declarations

:

: Ethics Committee of Medical Research at the College of Pharmacy /Hawler Medical University (HMU) has approved the current study. The reference No. of the ethical approval paper is HMU-PH-EC 191223/102. All procedures performed in a study involving human participants were under the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2013, and with the Ethics Committee of Medical Research at College of Pharmacy/Hawler Medical University.

: Written informed consent was taken from all the participants before participation in the current study. The potential subject informed of the right to refuse participation in the study or to withdraw consent to participate at any time without reprisal.

: Yes.

: The author declares no conflict of interests.

Document is current

Any future updates will be listed below